Literature DB >> 6220192

The role of mithramycin in the management of Paget's disease.

D A Heath.   

Abstract

18 patients with Paget's disease have received 27 courses of mithramycin therapy. This treatment has proved to be very effective in rapidly relieving bone pain due to Paget's disease--relief being apparent in 4 to 5 days. A dose of 10 micrograms/kg/day for 10 days is effective, well tolerated and to date free of serious side effects. Such treatment is particularly indicated in complicated cases with other possible explanations for the pain. Long term relief is unusual unless calcitonin or sodium etidronate is added.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6220192     DOI: 10.1016/0221-8747(81)90051-5

Source DB:  PubMed          Journal:  Metab Bone Dis Relat Res        ISSN: 0221-8747


  3 in total

1.  Carcinoma of the prostate: remission of paraparesis with inhibitors of bone resorption.

Authors:  R C Percival; M E Watson; J L Williams; J A Kanis
Journal:  Postgrad Med J       Date:  1985-06       Impact factor: 2.401

2.  Cardiac arrest associated with hypokalaemia in a patient receiving mithramycin.

Authors:  Y Bashir; C R Tomson
Journal:  Postgrad Med J       Date:  1988-03       Impact factor: 2.401

Review 3.  Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline.

Authors:  Stuart H Ralston; Luis Corral-Gudino; Cyrus Cooper; Roger M Francis; William D Fraser; Luigi Gennari; Núria Guañabens; M Kassim Javaid; Robert Layfield; Terence W O'Neill; R Graham G Russell; Michael D Stone; Keith Simpson; Diana Wilkinson; Ruth Wills; M Carola Zillikens; Stephen P Tuck
Journal:  J Bone Miner Res       Date:  2019-02-25       Impact factor: 6.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.